Viking Therapeutics Inc.

(VKTX) Trade

By |

Profile

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Contact Information

Website: www.vikingtherapeutics.com
Email: sdiaz@vidasp.com
Main Phone: +1 858 704-4660
Address: 12340 El Camino Real
Address 2: Suite 250
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NSC
CEO: Brian Lian
Employees: 17
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Contact Information

Website: www.vikingtherapeutics.com
Email: sdiaz@vidasp.com
Main Phone: +1 858 704-4660
Address: 12340 El Camino Real
Address 2: Suite 250
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NSC
CEO: Brian Lian
Employees: 17
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 6.58 $ -0.04 (-0.60%)
Last Price 6.58 Change $ -0.04 Change % -0.60 Tick N/A
Bid 6.40 Bid Size 300.00 Ask 7.25 Ask Size 200.00
Open 6.64 High 6.71 Low 6.53 Prev Close 6.62
Last Trade Volume 658,732 52 Wk Hi 15.69 52 Wk Low 6.15
Market Cap 475.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 72,210,630.00 EPS (TTM) -0.35 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 7 9
Number of Buys 4 6
Number of Sells 3 3
Net Activity 56212 111212
Last 10 Buys Shares
J. Matthew Singleton 1,000
Stephen W. Webster 1,000
Charles A. Rowland 1,000
Lawson Macartney 1,000
Matthew W. Foehr 1,000
Matthew W. Foehr 1,000
Matthew W. Foehr 1,000
Last 10 Sell Shares
Michael Morneau 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 13 15
Low Target Price Estimate 13 13 7.5 13
Mean Target Price Estimate 14.6 14.6 9.88 14.4
Standard Deviation 1.14 1.14 2.59 0.89
Date of Most Recent Estimate 06/01/18 06/01/18 05/14/18 06/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1